Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102982263 | 10298226 | 3 | F | 201401 | 20160711 | 20140711 | 20160721 | EXP | US-GLAXOSMITHKLINE-A1060546A | GLAXOSMITHKLINE | 60.52 | YR | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102982263 | 10298226 | 1 | PS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 220 MCG, 2 PUFFS | U | F0358 | 21433 | 2 | DF | BID | |||||
102982263 | 10298226 | 2 | SS | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | U | 0 | INHALATION POWDER | ||||||||||
102982263 | 10298226 | 3 | C | MAXAIR | PIRBUTEROL ACETATE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
102982263 | 10298226 | 1 | Asthma |
102982263 | 10298226 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
102982263 | 10298226 | Asthma | |
102982263 | 10298226 | Extra dose administered | |
102982263 | 10298226 | Product packaging confusion | |
102982263 | 10298226 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
102982263 | 10298226 | 1 | 2013 | 0 |